Medapp

Medapp Capital Intensity

The Capital Intensity Ratio of Medapp (MDA.WA) as of Nov 21, 2026 is 826.15 %. In the previous year, Capital Intensity Ratio was 446.01 % — a change of 85.23% (higher).

Capital Intensity

826.15 %

YoY

85.23%

Last updated:

Capital Intensity Ratio of Medapp is 2025 826.15 % . Capital Intensity Ratio of Medapp was 2024 446.01 % . It decreases by 85.23% higher compared to the previous year.

The Medapp Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
10,378.08 PLN
Jan 1, 2019
581.38 PLN
Jan 1, 2020
385.35 PLN
Jan 1, 2021
255.58 PLN
Jan 1, 2022
477.31 PLN
Jan 1, 2023
622.95 PLN
Jan 1, 2024
446.01 PLN
Jan 1, 2025
826.15 PLN
The Medapp Capital Intensity history
YEARCapital IntensityYoY
826.15 %+85.23%
446.01 %-28.40%
622.95 %+30.51%
477.31 %+86.75%
255.58 %-33.68%
385.35 %-33.72%
581.38 %-94.40%
10,378.08 %+106.19%
5,033.16 %-83.81%
31,079.79 %-58.98%
75,773.77 %+71,922.59%
105.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Capital Intensity Ratio of Medapp is 826.15 % in 2025.

Capital Intensity Ratio of Medapp changed from 446.01 % to 826.15 %, representing a 85.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Medapp since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Medapp with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Medapp

All Key Metrics — Medapp